Cargando…

Autophagic Markers in Chordomas: Immunohistochemical Analysis and Comparison with the Immune Microenvironment of Chordoma Tissues

SIMPLE SUMMARY: In contrast to normal notochords, autophagic factors are often present in chordomas. Furthermore, PD-L1+ immune cells also express LC3B, suggesting the need for further investigations between autophagy and the immune microenvironment. ABSTRACT: Chordomas are notably resistant to chem...

Descripción completa

Detalles Bibliográficos
Autores principales: Karpathiou, Georgia, Dridi, Maroa, Krebs-Drouot, Lila, Vassal, François, Jouanneau, Emmanuel, Jacquesson, Timothée, Barrey, Cédric, Prades, Jean Michel, Dumollard, Jean Marc, Meyronet, David, Boutonnat, Jean, Péoc’h, Michel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8124629/
https://www.ncbi.nlm.nih.gov/pubmed/33946484
http://dx.doi.org/10.3390/cancers13092169
_version_ 1783693263399550976
author Karpathiou, Georgia
Dridi, Maroa
Krebs-Drouot, Lila
Vassal, François
Jouanneau, Emmanuel
Jacquesson, Timothée
Barrey, Cédric
Prades, Jean Michel
Dumollard, Jean Marc
Meyronet, David
Boutonnat, Jean
Péoc’h, Michel
author_facet Karpathiou, Georgia
Dridi, Maroa
Krebs-Drouot, Lila
Vassal, François
Jouanneau, Emmanuel
Jacquesson, Timothée
Barrey, Cédric
Prades, Jean Michel
Dumollard, Jean Marc
Meyronet, David
Boutonnat, Jean
Péoc’h, Michel
author_sort Karpathiou, Georgia
collection PubMed
description SIMPLE SUMMARY: In contrast to normal notochords, autophagic factors are often present in chordomas. Furthermore, PD-L1+ immune cells also express LC3B, suggesting the need for further investigations between autophagy and the immune microenvironment. ABSTRACT: Chordomas are notably resistant to chemotherapy. One of the cytoprotective mechanisms implicated in chemoresistance is autophagy. There are indirect data that autophagy could be implicated in chordomas, but its presence has not been studied in chordoma tissues. Sixty-one (61) chordomas were immunohistochemically studied for autophagic markers and their expression was compared with the expression in notochords, clinicopathological data, as well as the tumor immune microenvironment. All chordomas strongly and diffusely expressed cytoplasmic p62 (sequestosome 1, SQSTM1/p62), whereas 16 (26.2%) tumors also showed nuclear p62 expression. LC3B (Microtubule-associated protein 1A/1B-light chain 3B) tumor cell expression was found in 44 (72.1%) tumors. Autophagy-related 16‑like 1 (ATG16L1) was also expressed by most tumors. All tumors expressed mannose-6-phosphate/insulin-like growth factor 2 receptor (M6PR/IGF2R). LC3B tumor cell expression was negatively associated with tumor size, while no other parameters, such as age, sex, localization, or survival, were associated with the immunohistochemical factors studied. LC3B immune cell expression showed a significant positive association with programmed death-ligand 1 (PD-L1)+ immune cells and with a higher vascular density. ATG16L1 expression was also positively associated with higher vascular density. Notochords (n = 5) showed different immunostaining with a very weak LC3B and M6PR expression, and no p62 expression. In contrast to normal notochords, autophagic factors such as LC3B and ATG16L1 are often present in chordomas, associated with a strong and diffuse expression of p62, suggesting a blocked autophagic flow. Furthermore, PD-L1+ immune cells also express LC3B, suggesting the need for further investigations between autophagy and the immune microenvironment.
format Online
Article
Text
id pubmed-8124629
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-81246292021-05-17 Autophagic Markers in Chordomas: Immunohistochemical Analysis and Comparison with the Immune Microenvironment of Chordoma Tissues Karpathiou, Georgia Dridi, Maroa Krebs-Drouot, Lila Vassal, François Jouanneau, Emmanuel Jacquesson, Timothée Barrey, Cédric Prades, Jean Michel Dumollard, Jean Marc Meyronet, David Boutonnat, Jean Péoc’h, Michel Cancers (Basel) Article SIMPLE SUMMARY: In contrast to normal notochords, autophagic factors are often present in chordomas. Furthermore, PD-L1+ immune cells also express LC3B, suggesting the need for further investigations between autophagy and the immune microenvironment. ABSTRACT: Chordomas are notably resistant to chemotherapy. One of the cytoprotective mechanisms implicated in chemoresistance is autophagy. There are indirect data that autophagy could be implicated in chordomas, but its presence has not been studied in chordoma tissues. Sixty-one (61) chordomas were immunohistochemically studied for autophagic markers and their expression was compared with the expression in notochords, clinicopathological data, as well as the tumor immune microenvironment. All chordomas strongly and diffusely expressed cytoplasmic p62 (sequestosome 1, SQSTM1/p62), whereas 16 (26.2%) tumors also showed nuclear p62 expression. LC3B (Microtubule-associated protein 1A/1B-light chain 3B) tumor cell expression was found in 44 (72.1%) tumors. Autophagy-related 16‑like 1 (ATG16L1) was also expressed by most tumors. All tumors expressed mannose-6-phosphate/insulin-like growth factor 2 receptor (M6PR/IGF2R). LC3B tumor cell expression was negatively associated with tumor size, while no other parameters, such as age, sex, localization, or survival, were associated with the immunohistochemical factors studied. LC3B immune cell expression showed a significant positive association with programmed death-ligand 1 (PD-L1)+ immune cells and with a higher vascular density. ATG16L1 expression was also positively associated with higher vascular density. Notochords (n = 5) showed different immunostaining with a very weak LC3B and M6PR expression, and no p62 expression. In contrast to normal notochords, autophagic factors such as LC3B and ATG16L1 are often present in chordomas, associated with a strong and diffuse expression of p62, suggesting a blocked autophagic flow. Furthermore, PD-L1+ immune cells also express LC3B, suggesting the need for further investigations between autophagy and the immune microenvironment. MDPI 2021-04-30 /pmc/articles/PMC8124629/ /pubmed/33946484 http://dx.doi.org/10.3390/cancers13092169 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Karpathiou, Georgia
Dridi, Maroa
Krebs-Drouot, Lila
Vassal, François
Jouanneau, Emmanuel
Jacquesson, Timothée
Barrey, Cédric
Prades, Jean Michel
Dumollard, Jean Marc
Meyronet, David
Boutonnat, Jean
Péoc’h, Michel
Autophagic Markers in Chordomas: Immunohistochemical Analysis and Comparison with the Immune Microenvironment of Chordoma Tissues
title Autophagic Markers in Chordomas: Immunohistochemical Analysis and Comparison with the Immune Microenvironment of Chordoma Tissues
title_full Autophagic Markers in Chordomas: Immunohistochemical Analysis and Comparison with the Immune Microenvironment of Chordoma Tissues
title_fullStr Autophagic Markers in Chordomas: Immunohistochemical Analysis and Comparison with the Immune Microenvironment of Chordoma Tissues
title_full_unstemmed Autophagic Markers in Chordomas: Immunohistochemical Analysis and Comparison with the Immune Microenvironment of Chordoma Tissues
title_short Autophagic Markers in Chordomas: Immunohistochemical Analysis and Comparison with the Immune Microenvironment of Chordoma Tissues
title_sort autophagic markers in chordomas: immunohistochemical analysis and comparison with the immune microenvironment of chordoma tissues
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8124629/
https://www.ncbi.nlm.nih.gov/pubmed/33946484
http://dx.doi.org/10.3390/cancers13092169
work_keys_str_mv AT karpathiougeorgia autophagicmarkersinchordomasimmunohistochemicalanalysisandcomparisonwiththeimmunemicroenvironmentofchordomatissues
AT dridimaroa autophagicmarkersinchordomasimmunohistochemicalanalysisandcomparisonwiththeimmunemicroenvironmentofchordomatissues
AT krebsdrouotlila autophagicmarkersinchordomasimmunohistochemicalanalysisandcomparisonwiththeimmunemicroenvironmentofchordomatissues
AT vassalfrancois autophagicmarkersinchordomasimmunohistochemicalanalysisandcomparisonwiththeimmunemicroenvironmentofchordomatissues
AT jouanneauemmanuel autophagicmarkersinchordomasimmunohistochemicalanalysisandcomparisonwiththeimmunemicroenvironmentofchordomatissues
AT jacquessontimothee autophagicmarkersinchordomasimmunohistochemicalanalysisandcomparisonwiththeimmunemicroenvironmentofchordomatissues
AT barreycedric autophagicmarkersinchordomasimmunohistochemicalanalysisandcomparisonwiththeimmunemicroenvironmentofchordomatissues
AT pradesjeanmichel autophagicmarkersinchordomasimmunohistochemicalanalysisandcomparisonwiththeimmunemicroenvironmentofchordomatissues
AT dumollardjeanmarc autophagicmarkersinchordomasimmunohistochemicalanalysisandcomparisonwiththeimmunemicroenvironmentofchordomatissues
AT meyronetdavid autophagicmarkersinchordomasimmunohistochemicalanalysisandcomparisonwiththeimmunemicroenvironmentofchordomatissues
AT boutonnatjean autophagicmarkersinchordomasimmunohistochemicalanalysisandcomparisonwiththeimmunemicroenvironmentofchordomatissues
AT peochmichel autophagicmarkersinchordomasimmunohistochemicalanalysisandcomparisonwiththeimmunemicroenvironmentofchordomatissues